Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: 12-Month Patient-Reported Outcomes from the BFORE Trial
暂无分享，去创建一个
T. Brümmendorf | J. Cortes | M. Deininger | C. Chuah | M. Mauro | C. Gambacorti-Passerini | A. Hochhaus | Dong-Wook Kim | P. Coutre | A. Reisman | I. Dyagil | C. Mamolo | N. Bardy-Bouxin | R. Crescenzo | N. Glushko | Laurence Reilly | A. Jeynes-Ellis | V. Gutiérrez | D. Milojkovic